Medindia LOGIN REGISTER
Medindia
Advertisement

Experimental Drug and Advanced Intensive Care Saves Ugandan Physician

by Kalyani Thivakaran on December 21, 2014 at 11:40 AM
 Experimental Drug and Advanced Intensive Care Saves Ugandan Physician

An Ugandan physician with Ebola who had been airlifted from Sierra Leone has been saved by a team of German doctors on Friday using an experimental drug together with advanced intensive care.

A prototype drug called FX06, designed to stop hemorrhage, was given to the patient after the doctors got special authorization from their hospital's ethics committee, they reported in The Lancet.

Advertisement

"Even though the patient was critically ill, we were able to support him long enough for his body to start antibody production and for the virus to be cleared by his body's defenses," said Timo Wolf of University Hospital Frankfurt.

The Frankfurt team and the makers of the experimental drug had announced its use in early November.

Publication in The Lancet, a leading peer-reviewed medical journal, validates this announcement.
Advertisement

The unnamed 38-year-old male doctor had been airlifted to Frankfurt in early October, five days after the onset of Ebola symptoms, and admitted to a Biosafety 4 facility, the highest level of medical security, the study said.

Within three days of admission, he was suffering from failure of the lungs, kidneys and gastro-intestinal tract, as well as hemorrhaging blood vessels, a hallmark of Ebola infection.

He was placed on a ventilator and kidney dialysis and administered with antibiotics and a three-day course of FX06.

Called a fibrin-derived peptide, FX06 is designed to seal off the walls of blood vessels, which become permeable when infected by a hemorrhagic virus.

The peptide works by binding to the surface of endothelial cells, which form the inner cell layer of blood vessels. It latches onto the cells via a target called VE-cadherin.

The drug was invented at Vienna General Hospital and is made by a small Austrian firm called MChE-F4Pharma.

It had previously been tested on lab mice infected with the dengue virus and was also put through a trial among 234 European patients to assess its potential for limiting damage to cardiac tissue after a heart attack.

The combination of intensive care and the drug helped the Ugandan patient to stabilize and then recover, the doctors reported.

After a 30-day observation period, no trace of Ebola was found in his blood, and he was released from hospital to return to his family.

But the Lancet study also reported that shortly after this case, another Ebola patient with acute Ebola and hemorrhage was treated with FX06 at a hospital in the eastern Germany city of Leipzig, but died.

Treating Ebola cases in intensive care is a task with "complexity and specific challenges," it warned.

FX06 is "a potentially valuable therapeutic candidate" for fighting the disease, the authors said, calling for the drug to be assessed in clinical trials.

More than 6,900 people have died in the latest Ebola epidemic, which is centered on the west African states of Guinea, Liberia and Sierra Leone, the World Health Organization (WHO) said on Wednesday.

Source: AFP
Font : A-A+

Advertisement

Advertisement
Advertisement

Recommended Readings

Latest Tropical Disease News

Monkeypox Outbreak Extends Across Five Indonesian Provinces
The viral infection of monkeypox has now spread to five provinces in Indonesia, said authorities.
Mpox Traced Back to 2016 Before 2022 Global Outbreak
Mpox, previously recognized as Monkeypox, has existed in human circulation since 2016, preceding the 2022 worldwide health emergency it initiated.
How Gut Bacteria Raise the Risk of Severe Malaria?
Gut bacteria composition is linked to a higher risk of severe malaria and may aid in developing new approaches to prevent severe malaria and its mortality.
Growing Monkeypox Outbreak in Indonesia Prompts Heightened Alert
Indonesia's Health Ministry is on high alert due to 14 confirmed monkeypox cases since its first detection on October 13.
Rare Zika Case Emerges in Cambodia After Seven Years
The Ministry of Health (MoH) in Cambodia has reported the first Zika virus case in the country since 2016.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
×

Experimental Drug and Advanced Intensive Care Saves Ugandan Physician Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests